risankizumab,tofacitinib,vedolizumab,azacitidine,ustekinumab,ozanimod,upadacitinib,adalimumab,golimumab,infliximab
abbvie,bms,janssen,takeda,pfizer
['ibd', ' uc ']
 lays out the current #ibd treatment landscape. next: how do we position them? #aibd2022 
Gastroenterologist with focus on #IBD and quality improvement @utswnews (Tweets mine, not medical advice, of course)